OCU400 demonstrated meaningful improvement of 2-line gain (10 letters on ETDRS chart) in low-luminance visual acuity (LLVA) in treated eyes when compared to untreated fellow eyes.
Ophthalmology Times – ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated. In order to…
This trial is designed to evaluate 4D-150 in diabetic macular edema.
Uveal melanoma (UM) poses significant diagnostic and prognostic challenges due to its variable genetic landscape. We explore the use of a novel deep-learning tool to…
Researchers have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD), potentially helping people…
We are pleased to invite you to participate in World Cornea Congress IX, taking place March 20-22, 2025, at the Westin Washington, DC Downtown. We’re…
This technology is showing promise for disease risk stratification, diagnostic imaging, patient scheduling, and educational applications.
➤ Topline Phase 3 pivotal study for BRIMOCHOL for treatment of presbyopia ➤ Positive Phase 2b/3 results for oral treatment of thyroid eye disease ➤…
Resources regarding recent devastation caused by wildfires
